Sunday, February 22, 2026

Latest

‘More of an Instinct’: Trump Explains How He’ll Decide Which Companies Get Tariff Exemptions

President Donald Trump revealed Wednesday he may grant exemptions to certain companies hurt by his sweeping tariffs based primarily on his “instinct” rather than established economic analysis.

“You almost can’t take a pencil to paper. It’s really more of an instinct than anything else,” Trump told reporters during a press conference with Treasury Secretary Scott Bessent. “Some companies, through no fault of their own, they happen to be in an industry that is more affected by these things than others.”

The vague process, without established guidelines or oversight, creates a situation where companies may need to appeal directly to the administration for relief. Trump’s statement that “you have to be able to show a little flexibility, and I’m able to do that” suggests a personalized approach to exemptions that could advantage businesses with stronger connections to the White House.

The administration has already carved out exemptions for approximately $644 billion in imports following Trump’s “Liberation Day” tariff announcements, which imposed a 10% universal tariff on imported goods plus higher “reciprocal” tariffs targeting China and European Union countries. 

The Wall Street Journal reports $185 billion of these exemptions benefit goods from Canada and Mexico, though these nations face other trade restrictions.

Trump’s approach to trade policy has introduced significant uncertainty for businesses. His metaphorical explanation about needing to go “under the wall, around the wall or over the wall” when obstacles appear did little to clarify his decision-making process, instead highlighting the unpredictable nature of the exemption system.

Pharmaceutical companies, temporarily exempted while undergoing a Section 232 investigation, may soon face what Trump described as “a major tariff” despite the ongoing review. At a National Republican Congressional Committee dinner Tuesday night, Trump indicated pharmaceutical tariffs would be announced “very soon,” suggesting the investigation’s outcome may already be predetermined.

Related: Kimbal, Elon Musk’s Brother, Calls Out Trump For “Permanent Tax” On US Consumer


Information for this story was found via the sources and companies mentioned. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

1911 Gold: The Power Of A Mine Restart

Is Gold Repeating the 2005 Setup Before The Big Run? | Geordie Mark

DPM Metals Q4 Earnings: Record Cash Flow vs Rising Costs

Recommended

Goliath Resources Sees 13% Grade Boost As Stifel Draws Parallels To Great Bear

First Majestic Q4 2025: Record Revenue, Earnings, Annual Silver Output

Related News

Jagmeet Singh Demands Parliament Recall Over US Tariff Threat

NDP Leader Jagmeet Singh called for an emergency Parliament session on Thursday to address looming...

Friday, January 31, 2025, 02:55:00 PM

Finally, Trump Realizes His Tariffs Are Hiking Grocery Prices

President Donald Trump is reportedly preparing to scale back tariffs on goods made with steel...

Saturday, February 14, 2026, 11:44:00 AM

Donald Trump Claims He Will Be Arrested On Tuesday, Calls For Protest

Former US President Donald Trump appears to be fearing arrest again. The former President this...

Saturday, March 18, 2023, 09:29:53 AM

Macron-Aligned Renew Europe Blasts “Unbalanced” US-EU Deal As Bloc Fact-Checks Trump’s Claims

Just hours after the US and EU reached a trade agreement, significant dissent has emerged...

Tuesday, July 29, 2025, 11:34:00 AM

Trump Targets Defense Contractors Over Buybacks

President Donald Trump escalated pressure on US defense contractors by tying capital return policies and...

Thursday, January 8, 2026, 11:24:00 AM